Higher vitamin K status not linked to less bone loss
An observational analysis of 771 US adults over two years also found no link between initial vitamin K status and bone-density responses to vitamin D.
Our read
Interventions- Studied:
- Cohort study of 687 generally healthy adults, 2-yr, against participants with lower vitamin K status (Double-blind, placebo-controlled, registered NCT04573946)
- What changed:
- Bone loss did not differ overall between participants with higher and lower vitamin K status over 2-yr follow-up
- The catch:
- Smoking and alcohol use differed by vitamin K status but were not adjustment factors
- In the record:
- The 328th paper on cholecalciferol with results in people; 481 on record in all.
Editor of record: Boris Djordjevic · AgingResearch.News
In 771 US men and women averaging 63.8 years old, researchers examined whether initial vitamin K status was linked to bone-density changes over two years. Women made up 46.7% of participants. This observational analysis used data from a randomized trial comparing 2,000 international units of vitamin D₃ daily with placebo.
Researchers assessed vitamin K status using three blood measures. Of the original participants, 687 completed follow-up bone-density scans. Higher initial vitamin K status was not linked to more favorable changes in bone density at the spine, hip or whole body, or in bone structure at the forearm and shin. Initial vitamin K status also did not modify vitamin D’s effects on bone density. Vitamin D itself produced no difference in bone-density changes compared with placebo.
Why it matters
Vitamin D stimulates production of a bone protein that vitamin K activates. This relationship raises the question of whether vitamin K status matters for efforts to preserve bone health in older adults.
Caveats
Vitamin K status was observed rather than randomized, so this was not a test of vitamin K supplements. Participants came from the Boston area; the trial excluded people with prior cardiovascular disease, most cancers and several serious illnesses.
From the paper
- Participants
About 388 participants were randomized to active vitamin D₃ intervention, and 383 were randomized to vitamin D placebo.
Results, Baseline characteristics of the bone health sub-cohort
Quoted word for word from the full text on PubMed Central.
- Vitamin K
- Cholecalciferol
- Areal bone mineral density
- Dephosphorylated undercarboxylated matrix Gla protein
- Percent undercarboxylated osteocalcin
- Humans
The paper
Brigham and Women's Hospital
JBMR Plus, Jul 3, 2026, Open access



Comments
Be the first to comment.